Zytega is a new medication for prostate cancer that works by blocking testosterone. It is superior to other medications for this purpose and I have personally seen strong results in patients who have used this after failing chemotherapy.
Now, a new report on the New England Journal of Medicine, shows that Zytega is effective at earlier points in treatment and can be used prior to resorting to chemotherapy.
This safe and effective medication will prove a boon to treatment at this point and is a welcome addition. The only issue with the medication is cost, but getting supportive research to prove effectiveness earlier in treatment will provide the incentive for insurance coverage for this medication